{"id":381,"date":"2024-01-08T15:55:43","date_gmt":"2024-01-08T14:55:43","guid":{"rendered":"https:\/\/www.symatese.com\/?page_id=381"},"modified":"2025-01-21T15:10:31","modified_gmt":"2025-01-21T14:10:31","slug":"our-story","status":"publish","type":"page","link":"https:\/\/www.symatese.com\/fr\/who-are-we\/our-story\/","title":{"rendered":"Notre histoire"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

L'HISTOIRE SYMATESE <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

D\u00e9couvrez notre histoire <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Eric P\u00e9rouse, pharmacien de formation, a d\u00e9but\u00e9 ses activit\u00e9s dans le secteur de la sant\u00e9 au d\u00e9but des ann\u00e9es 80 avec la cr\u00e9ation du LABORATOIRE P\u00c9ROUSE, d\u00e9di\u00e9 \u00e0 la st\u00e9rilisation puis \u00e0 la chirurgie vasculaire. En 1988, il se diversifie dans la technologie des silicones pour la chirurgie plastique avec le LABORATOIRE P\u00c9ROUSE IMPLANT. D'autres diversifications sont ensuite entreprises en 1990 avec les thermoplastiques pour les syst\u00e8mes d'administration suite \u00e0 l'acquisition de SEDAT, aujourd'hui sous le nom de SYMATESE DEVICE.<\/p>

L'acquisition de SADUC aupr\u00e8s de Pasteur M\u00e9rieux, alors impliqu\u00e9 dans le d\u00e9veloppement des collag\u00e8nes en 1997, marque l'ann\u00e9e de la cr\u00e9ation de SYMATESE avec Jean-Paul G\u00e9rardin, actuel PDG de SYMATESE.<\/p>

De 1997 \u00e0 aujourd'hui, SYMATESE n\u2019a cess\u00e9 d\u2019investir dans la recherche sur le collag\u00e8ne, l'acide hyaluronique et d'autres biopolym\u00e8res. La double expertise, unique sur le march\u00e9 des collag\u00e8nes et des acides hyaluroniques, demeure une cl\u00e9 essentielle pour faire avancer la recherche sur la r\u00e9g\u00e9n\u00e9ration tissulaire : les 2 biomat\u00e9riaux jouent un r\u00f4le compl\u00e9mentaire d\u00e9terminant dans les processus de r\u00e9paration naturelle des tissus vivants. C\u2019est d\u2019ailleurs cette volont\u00e9 qui marque le d\u00e9but de la coop\u00e9ration de recherche avec L'OR\u00c9AL \/ EPISKIN en 2001 pour une alternative aux tests sur animaux des produits cosm\u00e9tiques. La m\u00eame ann\u00e9e, PEROUSE PLASTIE a \u00e9galement lanc\u00e9 ses premiers implants mammaires en gel de silicone.<\/p>

D\u00e9couvrez en d\u00e9tail les principales \u00e9tapes du d\u00e9veloppement de SYMATESE \u00e0 travers les partenariats cl\u00e9s \u00e9tablis avec des entreprises leaders sur leurs march\u00e9s ainsi que les lancements de produits sous marque propre.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t
<\/div><\/div>\n\t
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
1997<\/div><\/div>
SYMATESE fond\u00e9e par des experts de l'industrie<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
1997<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2003<\/div><\/div>
Partenariat avec MEDTRON dans le domaine de l'IRM <\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2003<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2004<\/div><\/div>
Partenariat avec L'OR\u00c9AL dans le domaine de la science de la peau<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2004<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2006<\/div><\/div>
Partenariat avec BVI dans le domaine de l'ophtalmologie<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2006<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2007<\/div><\/div>
Implants mammaires PEROUSE PLASTIE c\u00e9d\u00e9s \u00e0 MENTOR<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2007<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2008<\/div><\/div>
Partenariat avec J&J dans le domaine du rachis <\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2008<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2011<\/div><\/div>
GALDERMA launches EMERVEL hyaluronic acid-based injectable products for facial rejuvenation developed by SYMATESE<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2011<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2018<\/div><\/div>
Partenariat dans les AH avec ABIOGEN, traitement intra-articulaire et VISANT MEDICAL, traitement de la s\u00e9cheresse oculaire <\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2018<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2021<\/div><\/div>
Renforcement du partenariat R&D avec L'OR\u00c9AL sur les biomat\u00e9riaux<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2021<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2023<\/div><\/div>
Partenariat avec EVOLUS, \u00c9tats-Unis (mai) et Europe (d\u00e9cembre), produits de comblement de rides \u00e0 base d'AH, nouvelle g\u00e9n\u00e9ration<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2023<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t\t
\"\"<\/div>\t\t\t\t
\n\t\t\t\t\t
2024<\/div><\/div>
NORDIC PHARMA lance LACRIFILL\u00ae, injectable \u00e0 base d\u2019acide hyaluronique d\u00e9velopp\u00e9 par SYMATESE pour le traitement de l\u2019\u0153il sec<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t
<\/div>\n\t<\/div>\n\t
<\/path><\/svg><\/span><\/div><\/div>
2024<\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

L'histoire des produits SYMATESE <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n\t
\n\t\t
\n\t\t\t
\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
SYMATESE fond\u00e9e par des experts de l'industrie<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Lancement de 2 produits : HEMOTESE\u00ae et COLLAPAT\u00ae II <\/div>
Voir le produit<\/a><\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Lancement du CLIP-INJECT pour la chirurgie oculaire <\/div>
Voir le produit<\/a><\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Lancement de la seringue SPP pour l'injection de produits \u00e0 haute viscosit\u00e9<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Lancement de NEVELIA\u00ae, matrice de r\u00e9g\u00e9n\u00e9ration dermique<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Approbation ANVISA, Br\u00e9sil ESTYME\u00ae MATRIX, nouvelle gamme d'implants mammaires<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Les injectables \u00e0 base d\u2019acide hyaluronique ESTYME\u00ae pour le visage obtiennent le marquage CE MDR<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n<\/div>\t\t\t
\n\t
<\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n<\/div>\t\t\t
\n
\n\t\t\t
1997<\/div>\t<\/div>\n\n
\n\t\t\t
2003<\/div>\t<\/div>\n\n
\n\t\t\t
2008<\/div>\t<\/div>\n\n
\n\t\t\t
2013<\/div>\t<\/div>\n\n
\n\t\t\t
2018<\/div>\t<\/div>\n\n
\n\t\t\t
2022<\/div>\t<\/div>\n\n
\n\t\t\t
2024<\/div>\t<\/div>\n<\/div>\t\t<\/div>\n\t<\/div>\n\t<\/svg><\/i><\/svg><\/i><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n\t
\n\t\t
\n\t\t\t
\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
SYMATESE fond\u00e9e par des experts de l'industrie<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partnership with MEDTRON in MRI \n\nLaunch of 2 products: HEMOTESE\u00ae and COLLAPAT\u00ae II <\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partenariat avec L'OR\u00c9AL dans le domaine de la science de la peau<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partenariat avec BVI dans le domaine de l'ophtalmologie<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Implants mammaires PEROUSE PLASTIE c\u00e9d\u00e9s \u00e0 MENTOR<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partnership with J&J in the spine. \n\nLaunch of CLIP-INJECT for surgery. <\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
GALDERMA lance les produits injectables EMERVEL \u00e0 base d\u2019acide hyaluronique pour le rajeunissement du visage d\u00e9velopp\u00e9s par SYMATESE<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
Lancement de la seringue SPP pour l'injection de produits \u00e0 haute viscosit\u00e9<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partnership technology HA with ABIOGEN, intra-articular treatment & VISANT MEDICAL, dry eye treatment. \n\nLaunch of NEVELIA\u00ae, dermal regeneration matrix.<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Reinforcing R&D partnership with L\u2019OR\u00c9AL on biomaterials.\n\nCE mark ESTYME\u00ae LIFT, 1st in a new generation of HA-based dermal fillers.<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
Approbation ANVISA, Br\u00e9sil ESTYME\u00ae MATRIX, nouvelle gamme d'implants mammaires<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n\n
\n\t\t\t\n
\n\t
\n\t\t
\"\"<\/div>
Partenariat avec EVOLUS, \u00c9tats-Unis (mai) et Europe (d\u00e9cembre), produits de comblement de rides \u00e0 base d'AH, nouvelle g\u00e9n\u00e9ration<\/div>\t<\/div>\n\t\t\t
<\/div>\n\t<\/div>\n\t<\/div>\n<\/div>\t\t\t
\n\t
<\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n\n
\n\t
<\/div><\/div><\/div>\n<\/div>\t\t\t
\n
\n\t\t\t
1997<\/div>\t<\/div>\n\n
\n\t\t\t
2003<\/div>\t<\/div>\n\n
\n\t\t\t
2004<\/div>\t<\/div>\n\n
\n\t\t\t
2006<\/div>\t<\/div>\n\n
\n\t\t\t
2007<\/div>\t<\/div>\n\n
\n\t\t\t
2008<\/div>\t<\/div>\n\n
\n\t\t\t
2011<\/div>\t<\/div>\n\n
\n\t\t\t
2013<\/div>\t<\/div>\n\n
\n\t\t\t
2018<\/div>\t<\/div>\n\n
\n\t\t\t
2021<\/div>\t<\/div>\n\n
\n\t\t\t
2022<\/div>\t<\/div>\n\n
\n\t\t\t
2023<\/div>\t<\/div>\n<\/div>\t\t<\/div>\n\t<\/div>\n\t<\/svg><\/i><\/svg><\/i><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

SYMATESE story Discover our story behind SYMATESE Eric Perouse, a pharmacist by training, started his activities in the health sector in the early 80s with the creation of LABORATOIRE P\u00c9ROUSE, dedicated to sterilization and then to vascular surgery and vascular access. In 1988, he diversified into silicone technology for plastic surgery with the LABORATOIRE P\u00c9ROUSE […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":16,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-381","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/pages\/381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/comments?post=381"}],"version-history":[{"count":20,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/pages\/381\/revisions"}],"predecessor-version":[{"id":4210,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/pages\/381\/revisions\/4210"}],"up":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/pages\/16"}],"wp:attachment":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/media?parent=381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}